Video del Mr Amit Shah
Webinar #4 Ovarian Cancer - the 'new normal' and future post-COVID
Descrizione:
Watchfully as Dr. Amit Shah discusses 'the new normal' in post-Covid-19 OC management, the pros and cons of the present OC landscape, as well as the expanding role of immunotherapy and targeted therapies in Covid-era OC, and which patient subgroups may benefit from these approaches. New methods of molecular testing have allowed clinicians to identify subgroups of patients with Ovarian Cancer, opening the door to a more personalized treatment selection for those with BRCAmut/BRCAwt/HRD +'ve/-'ve. Ongoing clinical trials in Ovarian Cancer, targeting biomarkers like CA125, HE4, CHI3L1, PEBP4, and/or AGR2, etc, have led to the introduction of exciting novel drugs (Niraparib, Olaparib, Bevacizumab, bevacizumab+olaparib combination, rucaparib, etc,). However, Covid-19 has resulted in a rethink as to how best to treat OC patients, and new pathways have been forced upon physicians. MDforLives conducts market research on niche sections of healthcare. Our process is structured to obtain maximum responses as well as accurate results. Earn up to $300 per survey for your medical expertise. Share your insights on healthcare and get rewarded. Sign up to be a part of the MDforlives community today. Never miss an opportunity to earn more points. MDforLives APP is available for free- Android - https://bit.ly/2STA3Yl iOS devices - https://apple.co/3cVGVvm For updates follow us to our social pages: Facebook: https://www.facebook.com/MDforLives Twitter: https://twitter.com/MDforLives Instagram: https://www.instagram.com/mdforlives/ LinkedIn: https://www.linkedin.com/company/mdfo... #MDforLives #healthcare #medicalexpertise #healthsurvey #marketresearch #doctors #physicians #healthcarecommunity #webinar2021 #blogs #casestudies